Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Shenzhen - Delayed Quote CNY

Tibet Cheezheng Tibetan Medicine Co., Ltd. (002287.SZ)

23.78
-0.04
(-0.17%)
At close: April 30 at 3:04:27 PM GMT+8
Currency in CNY All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
2,375,886.21
2,337,969.65
2,045,152.41
2,044,789.34
1,770,485.99
Cost of Revenue
424,803
418,374.98
323,314.88
324,139.54
265,342.49
Gross Profit
1,951,083.20
1,919,594.67
1,721,837.53
1,720,649.80
1,505,143.50
Operating Expense
1,327,225.66
1,307,918.03
1,088,724.77
1,118,915.98
1,007,282.94
Operating Income
623,857.54
611,676.64
633,112.76
601,733.83
497,860.56
Net Non Operating Interest Income Expense
-57,867.35
-53,858.05
-50,198.57
-39,906.31
-19,458.89
Pretax Income
621,980.20
646,244.19
644,412.87
519,202.33
787,914.13
Tax Provision
64,210.21
64,874.54
65,235.13
49,559.55
77,088.31
Net Income Common Stockholders
560,500.07
582,281.12
581,198.85
472,542.43
715,876.20
Basic EPS
1.06
1.10
1.10
0.89
1.35
Diluted EPS
1.06
1.10
1.10
0.89
1.35
Basic Average Shares
530,470.24
530,262.38
529,710.95
529,637.33
528,634.03
Diluted Average Shares
530,470.24
530,262.38
530,097.46
530,350.65
529,220.23
Total Operating Income as Reported
642,432.81
657,025.01
646,382.95
521,541.01
790,206.34
Rent Expense Supplemental
--
--
--
2,937.03
2,875.27
Total Expenses
1,752,028.67
1,726,293.01
1,412,039.65
1,443,055.51
1,272,625.43
Net Income from Continuing & Discontinued Operation
560,500.07
582,281.12
581,198.85
472,542.43
715,876.20
Normalized Income
475,402.46
488,687.53
549,994.17
478,529.24
710,527.30
Interest Income
-175.02
4,185.50
13,137.41
16,963.76
34,440.26
Interest Expense
56,723.18
57,787.37
63,069.77
56,423.46
53,426.65
Net Interest Income
-57,867.35
-53,858.05
-50,198.57
-39,906.31
-19,458.89
EBIT
678,703.38
704,031.56
707,482.64
575,625.79
841,340.78
EBITDA
678,703.38
843,371.23
800,722.99
658,813.49
907,172.62
Reconciled Cost of Revenue
424,803
418,374.98
323,314.88
324,139.54
265,342.49
Reconciled Depreciation
--
139,339.67
93,240.35
83,187.70
65,831.83
Net Income from Continuing Operation Net Minority Interest
560,500.07
582,281.12
581,198.85
472,542.43
715,876.20
Total Unusual Items Excluding Goodwill
94,894.01
104,037.61
34,719.39
-6,618.57
5,928.98
Total Unusual Items
94,894.01
104,037.61
34,719.39
-6,618.57
5,928.98
Normalized EBITDA
583,809.37
739,333.61
766,003.59
665,432.06
901,243.63
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
9,796.40
10,444.03
3,514.71
-631.76
580.08
12/31/2021 - 8/28/2009

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

222110.KQ PanGen Biotech Inc.
5,700.00
-1.72%
 
002030.SZ Daan Gene Co., Ltd.
5.63
+4.45%
 
GNMSF Genmab A/S
205.10
0.00%
 
028300.KQ HLB Co., Ltd.
57,400.00
+0.88%
 
207940.KS Samsung Biologics Co.,Ltd.
1,085,000.00
+3.14%
 
DTIL Precision BioSciences, Inc.
5.73
+0.18%
 
ALEC Alector, Inc.
1.2650
+3.69%
 
QLGN Qualigen Therapeutics, Inc.
3.3301
-6.63%
 
GMAB Genmab A/S
21.51
+2.77%
 
GMAB.CO Genmab A/S
1,413.50
+1.04%